ArticleCureus2024
A Mysterious Cause of Coagulopathy With Bleeding Diathesis.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin K is essential to produce functional vitamin K-dependent coagulation factors (prothrombin, factors VII, IX, and X). Vitamin K antagonists inhibit the normal activation of these factors, leading to bleeding manifestations of variable severity. Long-acting vitamin K antagonists or superwarfarins were developed as rodenticides and have a significantly longer half-life and greater potency when compared to warfarin. Intoxication with superwarfarins presents a typical clinical picture and evolution, but its diagnosis can be challenging without a clear ingestion history. We describe a case of a healthy 67-year-old man who presented with bleeding diathesis and severe anemia due to isolated coagulopathy. Laboratory evaluation showed prolonged coagulation times and very low levels of vitamin K-dependent coagulation factors. All other potential causes were ruled out, and superwarfarin intoxication was assumed, although we were unable to confirm unequivocal exposure. He was treated with high-dose vitamin K supplementation for two months until coagulation times normalized. He remained asymptomatic with no laboratory changes four months after the suspension of vitamin K.The management of a patient presenting with bleeding diathesis and coagulopathy can be challenging. A stepwise approach is helpful to reach the correct diagnosis and intoxication with long-acting vitamin K antagonists should be considered, even without an ingestion history. Therapy with vitamin K in high doses must be started as soon as possible and can be lifesaving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.